Related Experiment Video

Updated: Jun 19, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Multidrug resistance-associated protein 2 gene (ABCC2) variant in kidney allograft recipients

J Pazik1, M Ołdak, E Sitarek

  • 1Department of Nephrology and Transplantation Medicine, Transplantation Institute, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland. jpazik@poczta.fm

Transplantation Proceedings
|October 28, 2009
PubMed

Insights

The ABCC2 4544A>G polymorphism in renal transplant recipients may impact outcomes. The A allele was linked to longer observation times and increased proteinuria risk, suggesting a role in transplantation success.

Area of Science:

  • Pharmacogenomics
  • Transplantation immunology
  • Renal medicine

Background:

  • Multidrug resistance-associated proteins (MRPs) are vital for protecting organs like kidneys and liver from toxins.
  • The role of MRPs, specifically the ABCC2 gene, in transplanted organ function and survival remains largely unexplored.
  • Understanding genetic variations in MRPs is crucial for optimizing transplant outcomes.

Purpose of the Study:

  • To investigate the frequency of the functional ABCC2 4544A>G polymorphism in 165 renal transplant recipients.
  • To determine the association between ABCC2 4544A>G genotypes and clinical outcomes in kidney transplant patients.
  • To explore the potential impact of this polymorphism on graft survival and complications like proteinuria.

Main Methods:

  • DNA was extracted from the peripheral blood of 165 renal transplant recipients.
  • The ABCC2 4544A>G polymorphism was genotyped using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique.
  • Allele and genotype frequencies were analyzed in relation to clinical data.

Main Results:

  • The study evaluated the allele and genotype frequencies of the ABCC2 4544A>G polymorphism.
  • The presence of the ABCC2 4544 A allele was associated with a prolonged observation period post-transplantation.
  • A correlation was found between the ABCC2 4544 A allele and a higher incidence of proteinuria.

Conclusions:

  • Specific alleles of the ABCC2 gene, including the 4544 A allele, may influence the outcomes of renal transplantation.
  • The ABCC2 4544A>G polymorphism could serve as a predictive marker for complications such as proteinuria in kidney transplant recipients.
  • Further research is warranted to elucidate the precise mechanisms by which ABCC2 variants affect long-term graft function and survival.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...